Epidemiology and genetic diversity of human respiratory syncytial virus in Belgium between 2011 and 2019

Epidemiology and genetic diversity of human respiratory syncytial virus in Belgium between 2011 and 2019

Abstract Background Human respiratory syncytial virus (HRSV) is worldwide one of the leading causes of acute respiratory tract infections in young children and the elderly population. Two distinct subtypes of HRSV (A and B) and a multitude of genotypes have been described. The laboratory of Clinical...

Full description

Saved in:

Bibliographic Details
Main Authors:	Kaat Ramaekers, Els Keyaerts, Lieselot Houspie, Kurt Beuselinck, Marijke Reynders, Katrien Lagrou, Marc Van Ranst, Annabel Rector
Format:	Article
Language:	English
Published:	BMC 2024-10-01
Series:	Virology Journal
Subjects:	Human respiratory syncytial virus Belgium Seasonality Epidemiology Respiratory health
Online Access:	https://doi.org/10.1186/s12985-024-02542-4
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Circulation of Respiratory Syncytial Virus (RSV) in Poland Between Seasons of 2009/2010 and 2022/2023 Based on SENTINEL System
by: Karol Szymański, et al.
Published: (2025-01-01)

Respiratory Syncytial Virus (RSV) Hospitalization Seasonal Patterns and Economic Burden in the US: Implications for Further Optimizing the Use of RSV Preventives
by: Amy W. Law, et al.
Published: (2025-03-01)

Characterisation of the respiratory syncytial virus seasonality and its environmental factors in the Americas—a multi-country observational study using routine surveillance networksResearch in context
by: Paula Couto, et al.
Published: (2025-08-01)

The Impact of Palivizumab for Respiratory Syncytial Virus Prophylaxis on Preschool Childhood Asthma
by: Hannah Ora Hasson, et al.
Published: (2024-11-01)

Long-Term Trends in Respiratory Syncytial Virus A Infections (2007–2024) in Korea
by: Jeong Su Han, et al.
Published: (2025-05-01)

Improving the quality of care of respiratory syncytial virus in the neonatal and pediatric populations globally
by: Fungwe Jah, et al.
Published: (2025-05-01)

ACUTE RESPIRATORY SYNCYTIAL VIRUS INFECTION IN CHILDREN IN THE AGE ASPECT
by: V. B. Rovny, et al.
Published: (2015-08-01)

Palivizumab for the Prophylaxis of Respiratory Syncytial Virus Disease: Expert Opinion and Recommendations for the Gulf Cooperation Council Region
by: Adel S. Alharbi, et al.
Published: (2024-09-01)

Effectiveness of palivizumab immunoprophylaxis in infants with respiratory syncytial virus disease in Colombia
by: Juan Gabriel Piñeros, et al.
Published: (2021-11-01)

Generation of nanobodies against the F protein of respiratory syncytial virus and establishment of an indirect immunofluorescence assay
by: Qianqian Wang, et al.
Published: (2025-07-01)

Adherence to Palivizumab for Respiratory Syncytial Virus Prophylaxis in Romanian Infants
by: Andreea Calomfirescu-Avramescu, et al.
Published: (2025-02-01)

CLINICAL AND PATHOMORPHOLOGICAL MANIFESTATIONS OF RESPIRATORY SYNCYTIAL VIRUS INFECTION. CASE REPORT
by: I. V. Babachenko, et al.
Published: (2018-04-01)

Characteristics of respiratory syncytial virus infection in children in Pudong New Area， Shanghai， 2013‒2023
by: YU Qiumiao, et al.
Published: (2025-05-01)

Diagnosis of Community-Acquired Pneumonia Due to Influenza or Respiratory Syncytial Virus: Evaluation of RT-PCR Sensitivity in Nasopharyngeal, Saliva, and Sputum Samples
by: Julio Ramirez, et al.
Published: (2025-04-01)

Seroprevalence of RSV IgG Antibodies Across Age Groups in Poland After the COVID-19 Pandemic: Data from the 2023/2024 Epidemic Season
by: Barbara Poniedziałek, et al.
Published: (2025-07-01)

IMMUNOPROPHYLAXIS OF SEVERE RESPIRATORY-SYNCYTIAL VIRAL INFECTION IN CHILDREN WITH BRONCHOPULMONARY DYSPLASIA: RESULTS OF 4 EPIDEMIC SEASONS
by: A. A. Baranov, et al.
Published: (2012-12-01)

Epidemiological and Clinical Characteristics of Respiratory Syncytial Virus Infection in Children in Hangzhou (2022–2023)
by: Qin-Rui Lai, et al.
Published: (2025-06-01)

Genotypic Characterization of Human Respiratory Syncytial Viruses Detected in Mexico Between 2021 and 2024
by: Nadia Martínez-Marrero, et al.
Published: (2025-04-01)

Call to include breastfeeding as a synergistic approach to vaccines for prevention of respiratory syncytial virus disease
by: Laura Fischer, et al.
Published: (2025-03-01)

A Review of Recent Cluster of Hospitalization-related Respiratory Syncytial Virus Infection Post-COVID-19: A Cross-sectional Study
by: Khalid Al Dhuhli, et al.
Published: (2024-01-01)

Predicting ICU Admission Risk in Children with Respiratory Syncytial Virus
by: Young Hwa Lee, et al.
Published: (2025-04-01)

Clinical features of respiratory syncytial virus and influenza infections in hospitalized adults across three Italian regions
by: Tommaso Bigoni, et al.
Published: (2025-04-01)

Epidemiology and clinical characteristics of hospitalized adults with respiratory syncytial virus infection at a medical center in northern Taiwan
by: Wen-Cheng Chang, et al.
Published: (2024-12-01)

Impact of Respiratory Syncytial Virus (RSV) in Adults 60 Years and Older in Spain
by: Sara Jimeno Ruiz, et al.
Published: (2024-11-01)

Genomic characterization and phylogenetic analysis of respiratory syncytial virus F gene in Sri Lanka: a comparative study
by: Thejanee Perera, et al.
Published: (2025-07-01)

THE EFFICACY OF THE COSTS ON SEVERE RESPIRATORY SYNCYTIAL INFECTION PREVENTION WITH PALIVIZUMAB IN PRETERM INFANTS
by: A. V. Rudakova, et al.
Published: (2012-07-01)

Turkish pediatricians’ knowledge, attitudes, and awareness of respiratory syncytial virus (RSV) infection and immunization strategies: a cross-sectional study
by: İsmail Yıldız, et al.
Published: (2025-05-01)

Out-of-pocket costs, time burden, and caregiver quality of life associated with pediatric medically attended respiratory syncytial virus illnesses
by: Angela M. Rose, et al.
Published: (2025-08-01)

Respiratory Syncytial Virus Lower Respiratory Tract Infections in Premature Infants and Infants with Bronchopulmonary Dysplasia
by: D. Yu. Ovsyannikov, et al.
Published: (2015-10-01)

The Epidemiology of Respiratory Syncytial Virus and the Impact of the COVID-19 Pandemic in a Retrospective Evaluation
by: Paolo Solidoro, et al.
Published: (2025-04-01)

Respiratory Syncytial Virus: What is the Risk Over 60?
by: Oğuzhan Acet, et al.
Published: (2024-12-01)

Description of respiratory syncytial virus genotypes circulating in Colombia
by: Viviana Avila, et al.
Published: (2018-12-01)

RESPIRATORY SYNCYTIAL VIRUS INFECTION: CLINICAL AND LABORATORY FEATURES
by: E. V. Mikhaylova, et al.
Published: (2017-07-01)

Perceptions about respiratory syncytial virus (RSV) and attitudes toward the RSV vaccine among the general public in China: A cross-sectional survey
by: Qiang Wang, et al.
Published: (2024-12-01)

Respiratory syncytial virus and human metapneumovirus in severe lower respiratory tract infections in children under two
by: Heba Taher Othman, et al.
Published: (2016-03-01)

Progress on Respiratory Syncytial Virus Vaccine Development and Evaluation Methods
by: Lie Deng, et al.
Published: (2025-03-01)

Recent trends in hospitalizations for respiratory syncytial virus after the COVID-19 pandemic and before routine immunization: Seasonality and severity updates from the 2023/2024 season in Tuscany, Italy
by: Vieri Lastrucci, et al.
Published: (2025-05-01)

Prevention of respiratory syncytial virus infection in children. Recommendations of the Polish Society of Paediatrics and the National Paediatric Consultant
by: Teresa Jackowska, et al.
Published: (2024-12-01)

Profile of Children Admitted with Respiratory Syncytial Virus Infections in a Quaternary Care Hospital in Kerala, India
by: Irshad M, et al.
Published: (2024-11-01)

Risk of nosocomial respiratory syncytial virus versus influenza among adult patients in acute care hospitals
by: Raija Auvinen, et al.
Published: (2025-03-01)